Kai Treuner

1.0k total citations
41 papers, 719 citations indexed

About

Kai Treuner is a scholar working on Cancer Research, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kai Treuner has authored 41 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 18 papers in Genetics and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kai Treuner's work include Breast Cancer Treatment Studies (20 papers), Estrogen and related hormone effects (15 papers) and Advanced Breast Cancer Therapies (14 papers). Kai Treuner is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Estrogen and related hormone effects (15 papers) and Advanced Breast Cancer Therapies (14 papers). Kai Treuner collaborates with scholars based in United States, Canada and United Kingdom. Kai Treuner's co-authors include Rolf Knippers, Carrolee Barlow, U. Ramsperger, Catherine A. Schnabel, Dennis C. Sgroi, Ranelle Salunga, Tammy Piper, John M.S. Bartlett, Daniel Rea and Sarah Pirrie and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kai Treuner

39 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai Treuner United States	14	397	307	238	218	141	41	719
Jikui Guan Sweden	15	415 1.0×	134 0.4×	160 0.7×	120 0.6×	88 0.6×	26	721
Gilad Landan United States	9	875 2.2×	257 0.8×	101 0.4×	209 1.0×	73 0.5×	12	1.1k
Filipe V. Jacinto Spain	11	799 2.0×	158 0.5×	69 0.3×	139 0.6×	34 0.2×	12	915
Anne Laugesen Denmark	8	1.1k 2.9×	192 0.6×	71 0.3×	161 0.7×	57 0.4×	9	1.3k
Hungjiun Liaw Taiwan	15	756 1.9×	192 0.6×	174 0.7×	62 0.3×	26 0.2×	27	868
Ngan Ching Cheng Australia	13	681 1.7×	236 0.8×	109 0.5×	186 0.9×	39 0.3×	20	899
Barry J. Coull United Kingdom	12	1.0k 2.6×	285 0.9×	201 0.8×	188 0.9×	87 0.6×	14	1.2k
Tomoatsu Hayashi Japan	12	355 0.9×	111 0.4×	93 0.4×	80 0.4×	44 0.3×	21	487
David Jakubosky United States	9	491 1.2×	53 0.2×	177 0.7×	139 0.6×	75 0.5×	9	645
Olivia Corradin United States	10	934 2.4×	223 0.7×	55 0.2×	195 0.9×	36 0.3×	15	1.1k

Countries citing papers authored by Kai Treuner

Since Specialization

Citations

This map shows the geographic impact of Kai Treuner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Treuner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Treuner more than expected).

Fields of papers citing papers by Kai Treuner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Treuner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Treuner. The network helps show where Kai Treuner may publish in the future.

Co-authorship network of co-authors of Kai Treuner

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Treuner. A scholar is included among the top collaborators of Kai Treuner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Treuner. Kai Treuner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salunga, Ranelle, Wilma E. Mesker, Linda de Munck, et al.. (2025). Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index. Clinical Cancer Research. 31(11). 2222–2229. 1 indexed citations

Bartlett, John M.S., Ranelle Salunga, Linda de Munck, et al.. (2025). Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer. npj Breast Cancer. 12(1). 21–21.

Li, Ma, Jianping Zhao, Jeannelyn S. Estrella, et al.. (2025). Clinicopathological characteristics of cancer of unknown primary (CUP) with renal profile using gene expression profiling (GEP) based cancer classification.. Journal of Clinical Oncology. 43(5_suppl). 456–456. 1 indexed citations

Mamounas, Eleftherios P., Hanna Bandos, Priya Rastogi, et al.. (2024). Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical Cancer Research. 30(9). 1984–1991. 7 indexed citations

Sanft, Tara, Rachel C. Jankowitz, Mark D. Pegram, et al.. (2024). Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study. Journal of the National Comprehensive Cancer Network. 22(2). 99–107. 1 indexed citations

Li, Ma, et al.. (2024). PP01.30 Integration of molecular cancer classification and NGS to identify patients with cancer of unknown primary (CUP) and other unclear diagnoses eligible for KRAS inhibitors. Journal of Thoracic Oncology. 19(7). e19–e19. 1 indexed citations

Bartlett, John M.S., Keying Xu, Gregory R. Pond, et al.. (2024). Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial. Clinical Cancer Research. 30(8). 1509–1517. 2 indexed citations

Wasan, Harpreet, Jiazhao Wang, Elaine McCartney, et al.. (2023). LBA100 CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes. Annals of Oncology. 34. S1339–S1339. 2 indexed citations

Bartlett, John M.S., Keying Xu, Gregory R. Pond, et al.. (2023). Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.. Journal of Clinical Oncology. 41(16_suppl). 509–509. 1 indexed citations

10.

O’Regan, Ruth, Gini F. Fleming, Prudence A. Francis, et al.. (2023). Abstract GS1-06: Evaluation of the Breast Cancer Index in premenopausal women with early-stage HR+ breast cancer in the SOFT trial. Cancer Research. 83(5_Supplement). GS1–6. 2 indexed citations

11.

Bartlett, John M.S., Dennis C. Sgroi, Kai Treuner, et al.. (2022). Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study. Clinical Cancer Research. 28(9). 1871–1880. 25 indexed citations

12.

Sgroi, Dennis C., Kai Treuner, Yi Zhang, et al.. (2022). Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study. Breast Cancer Research. 24(1). 90–90. 5 indexed citations

13.

Nunes, Raquel, Tal Sella, Kai Treuner, et al.. (2021). Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma. Clinical Cancer Research. 27(20). 5688–5696. 13 indexed citations

14.

Liefers, Gerrit‐Jan, Iris Noordhoek, Dennis C. Sgroi, et al.. (2021). 7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer. Annals of Oncology. 32. S23–S24. 2 indexed citations

15.

Bartlett, John M.S., Ikhlaaq Ahmed, Kai Treuner, et al.. (2021). 11P A Breast Cancer Index (BCI) prognostic model for N0 HR+ breast cancer optimized for late distant recurrence. Annals of Oncology. 32. S25–S25. 1 indexed citations

16.

Noordhoek, Iris, Kai Treuner, Hein Putter, et al.. (2020). Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy. Clinical Cancer Research. 27(1). 311–319. 73 indexed citations

17.

Miles, Philip D.G., et al.. (2007). Impaired insulin secretion in a mouse model of ataxia telangiectasia. American Journal of Physiology-Endocrinology and Metabolism. 293(1). E70–E74. 53 indexed citations

18.

Treuner, Kai, et al.. (2004). Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice. Oncogene. 23(27). 4655–4661. 28 indexed citations

19.

Treuner, Kai, et al.. (1999). Phosphorylation of Replication Protein A Middle Subunit (RPA32) Leads to a Disassembly of the RPA Heterotrimer. Journal of Biological Chemistry. 274(22). 15556–15561. 45 indexed citations

20.

Treuner, Kai, U. Ramsperger, & Rolf Knippers. (1996). Replication Protein A Induces the Unwinding of Long Double-stranded DNA Regions. Journal of Molecular Biology. 259(1). 104–112. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact